These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3293334)

  • 41. Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties.
    Miyazaki S; Iwasaki M; Sakaguchi G
    Infect Immun; 1977 Aug; 17(2):395-401. PubMed ID: 892912
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro reconstitution of the Clostridium botulinum type D progenitor toxin.
    Kouguchi H; Watanabe T; Sagane Y; Sunagawa H; Ohyama T
    J Biol Chem; 2002 Jan; 277(4):2650-6. PubMed ID: 11713244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular composition of the 16S toxin produced by a Clostridium botulinum type D strain, 1873.
    Nakajima H; Inoue K; Ikeda T; Fujinaga Y; Sunagawa H; Takeshi K; Ohyama T; Watanabe T; Inoue K; Oguma K
    Microbiol Immunol; 1998; 42(9):599-605. PubMed ID: 9802560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antigenicites of fragments of Clostridium botulinum type B derivative toxin.
    Kozaki S; Sakaguchi G
    Infect Immun; 1975 May; 11(5):932-6. PubMed ID: 804447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experimental botulism in Pekin ducks.
    Notermans S; Dufrenne J; Kozaki S
    Avian Dis; 1980; 24(3):658-64. PubMed ID: 7004433
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Collaborative study of a method for the detection of Clostridium botulinum and its toxins in foods.
    Kautter DA; Solomon HM
    J Assoc Off Anal Chem; 1977 May; 60(3):541-5. PubMed ID: 323214
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of neutral sugars in purified type G botulinum progenitor toxin and the effects of some glycolytic enzymes on its molecular dissociation and oral toxicity.
    Nukina M; Miyata T; Sakaguchi S; Sakaguchi G
    FEMS Microbiol Lett; 1991 Apr; 63(2-3):159-64. PubMed ID: 1905654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum type F neurotoxin. Large-scale purification and characterization of its binding to rat cerebrocortical synaptosomes.
    Wadsworth JD; Desai M; Tranter HS; King HJ; Hambleton P; Melling J; Dolly JO; Shone CC
    Biochem J; 1990 May; 268(1):123-8. PubMed ID: 2188647
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapid method for purification of Clostridium botulinuh type C neurotoxin by High Performance Liquid Chromatography (HPLC ).
    Matsuda M; Ozutsumi K; Pei-Ying D; Sugimoto N
    Eur J Epidemiol; 1986 Dec; 2(4):265-271. PubMed ID: 29464575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enzyme-linked immunosorbent assay for detection of Clostridium botulinum toxin type A.
    Notermans S; Dufrenne J; Schothorst M
    Jpn J Med Sci Biol; 1978 Feb; 31(1):81-5. PubMed ID: 351243
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isolation and molecular size of Clostridium botulinum type C toxin.
    Syuto B; Kubo S
    Appl Environ Microbiol; 1977 Feb; 33(2):400-5. PubMed ID: 403861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Repression of toxin production by tryptophan in Clostridium botulinum type E.
    Leyer GJ; Johnson EA
    Arch Microbiol; 1990; 154(5):443-7. PubMed ID: 2256780
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Growth of Clostridium botulinum in media with garlic (Allium sativum)].
    Giménez MA; Solanes RE; Giménez DF
    Rev Argent Microbiol; 1988; 20(1):17-24. PubMed ID: 3051126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for plasmid-mediated toxin and bacteriocin production in Clostridium botulinum type G.
    Eklund MW; Poysky FT; Mseitif LM; Strom MS
    Appl Environ Microbiol; 1988 Jun; 54(6):1405-8. PubMed ID: 2843093
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Purification and some properties of "Clostridium perfringens" delta toxin (author's transl)].
    Tixier G; Alouf JE
    Ann Microbiol (Paris); 1976; 127B(4):509-24. PubMed ID: 192118
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Production of a homogeneous Cl. botulinum type B neurotoxin].
    Saprykina TP; Kliucheva VV; Blagoveshchenskiĭ VA; Mironova MV
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Sep; (9):86-91. PubMed ID: 6778041
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of Botulinum Neurotoxin Synthesis and Toxin Complex Formation by Arginine and Glucose in Clostridium botulinum ATCC 3502.
    Fredrick CM; Lin G; Johnson EA
    Appl Environ Microbiol; 2017 Jul; 83(13):. PubMed ID: 28455330
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of a protease in natural activation of Clostridium botulinum neurotoxin.
    Das Gupta BR; Sugiyama H
    Infect Immun; 1972 Oct; 6(4):587-90. PubMed ID: 4564288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Production of the trypsin-activable toxin by Clostridium botulinum type C and D strains (author's transl)].
    Nakane A
    Nihon Saikingaku Zasshi; 1977 Nov; 32(6):805-11. PubMed ID: 342740
    [No Abstract]   [Full Text] [Related]  

  • 60. The combined effect of sub-optimal temperature and sub-optimal pH on growth and toxin formation from spores of Clostridium botulinum.
    Graham AF; Lund BM
    J Appl Bacteriol; 1987 Nov; 63(5):387-93. PubMed ID: 3326865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.